FDA
Pharma

Vinay Prasad is back at the FDA after last month's surprise ouster

“At the FDA’s request,” Vinay Prasad, M.D., is returning to lead CBER, an HHS spokesperson told Fierce Pharma.
Angus Liu Aug 9, 2025 12:22pm
Boehringer Ingelheim

Boehringer's lung cancer med passes muster with the FDA

Aug 8, 2025 3:52pm
CDC Free Mind campaign

CDC unveils campaign targeting teen substance use, mental health

Aug 8, 2025 11:49am
Gilead

Gilead reports 7% sales decline for CAR-Ts Yescarta, Tecartus

Aug 8, 2025 11:40am
FDA

FDA restricts bluebird's gene therapy after blood cancer reports

Aug 8, 2025 11:19am
settlement lawsuit litigation

GSK nabs $320M in CureVac patent settlement

Aug 8, 2025 10:46am
More News

Sanofi, Trump, VC capital crunch—Fierce Pharma Asia

Aug 8, 2025 9:32am

Is Trump’s MFN pricing order more bark than bite?

Aug 8, 2025 9:18am

Genmab touts new data that set up Epkinly for FL expansion

Aug 8, 2025 7:25am

FDA debuts new program to ease US manufacturing plant setup

Aug 7, 2025 3:16pm